Next Generation Melanoma Vaccine May Boost Long-term Survival, Especially in Young Men
A second-generation melanoma vaccine improves long-term survival for melanoma patients, especially among younger men, new research shows. The vaccine developers enhanced the effectiveness of their first-generation melanoma vaccine by simultaneously stimulating helper T cells to recognize melanoma proteins, in addition to weaponizing killer T cells against melanoma. This approach boosted patient survival and helped prevent […]